Carl P. Sherr & Co’s CVS Health CVS Stock Holding History

Carl P. Sherr & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,802	Closed	-$300K	–	123
2023 Q4	$300K	Sell	3,802 -570	-13%	-$40.6K	0.18%	94
2023 Q3	$305K	Hold	4,372	–	–	0.21%	91
2023 Q2	$302K	Hold	4,372	–	–	0.2%	94
2023 Q1	$325K	Hold	4,372	–	–	0.23%	83
2022 Q4	$407K	Sell	4,372 -870	-17%	-$83.9K	0.31%	73
2022 Q3	$500K	Buy	5,242 +141	+3%	+$14K	0.4%	63
2022 Q2	$473K	Sell	5,101 -75	-1%	-$7.32K	0.35%	73
2022 Q1	$524K	Hold	5,176	–	–	0.35%	73
2021 Q4	$534K	Sell	5,176 -1,748	-25%	-$162K	0.32%	76
2021 Q3	$588K	Buy	6,924 +4	+0.1%	+$335	0.47%	57
2021 Q2	$577K	Sell	6,920 -195	-3%	-$16K	0.4%	64
2021 Q1	$535K	Sell	7,115 -1,395	-16%	-$102K	0.4%	66
2020 Q4	$581K	Sell	8,510 -233	-3%	-$15.2K	0.46%	64
2020 Q3	$511K	Sell	8,743 -5,519	-39%	-$343K	0.46%	65
2020 Q2	$927K	Buy	14,262 +1,506	+12%	+$94.8K	0.92%	25
2020 Q1	$757K	Sell	12,756 -85	-0.7%	-$5.67K	0.9%	33
2019 Q4	$954K	Buy	+12,841	New	+$902K	0.93%	34

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carl P. Sherr & Co's CVS Position: Q1 2024 in Review

Carl P. Sherr & Co sold out of CVS Health (CVS) in Q1 2024, closing a stake of 3,802 shares — an estimated $300K sold.

Carl P. Sherr & Co first reported a position in CVS in Q4 2019 and held it in 17 quarters. The position peaked at $954K in Q4 2019. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

Carl P. Sherr & Co reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
Carl P. Sherr & Co sold 3,802 CVS Health shares in Q1 2024, an estimated $300K.
Carl P. Sherr & Co first reported a position in CVS Health in Q4 2019 and held it in 17 quarters.
Carl P. Sherr & Co's CVS Health position peaked at $954K in Q4 2019.
2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Carl P. Sherr & Co's 13F filing for Q1 2024, filed 2 May 2024.